Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3.

Tanja Selic Kurincic,Lesnicar G,Mario Poljak,Jelka Meglic Volkar,Mojca Rajter,Janja Prah,Zvonko Baklan,Tadeja Kotar,Mojca Matičič

Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3.

2014

Tanja Selic Kurincic
Lesnicar G
Mario Poljak
Jelka Meglic Volkar
Mojca Rajter
Janja Prah
Zvonko Baklan
Tadeja Kotar
Mojca Matičič

Objectives: The combination of pegylated interferon-α and ribavirin is a standard-of-care (SOC) treatment for chronic hepatitis C (CHC), and it achieves a sustain

Keywords:

Hepatitis C
Fluvastatin
Virology
Ribavirin
Genotype
Biology
standard of care
virological response
chronic hepatitis
pegylated interferon α

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations